TUDOR INVESTMENT CORP ET AL - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$49,382,000
+15829.7%
2,618,371
+9844.1%
1.70%
+18733.3%
Q2 2019$310,000
+66.7%
26,331
+44.8%
0.01%
+125.0%
Q4 2018$186,000
-67.8%
18,184
-47.6%
0.00%
-73.3%
Q3 2018$578,000
+204.2%
34,717
+189.0%
0.02%
+114.3%
Q2 2018$190,000
-86.1%
12,013
-89.2%
0.01%
-80.0%
Q3 2017$1,367,000
+147.2%
111,615
+131.1%
0.04%
+105.9%
Q2 2017$553,000
-6.3%
48,304
+168.1%
0.02%
-15.0%
Q3 2015$590,000
-14.2%
18,017
+38.8%
0.02%0.0%
Q2 2015$688,000
+170.9%
12,982
+47.3%
0.02%
+150.0%
Q1 2015$254,0008,8160.01%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders